POP-PHARM is pleased to announce the expansion of his business activities toward full unlimited support to SADAPT, NONMEM7 and MC-PEM programs.
NONMEM 7 has been improved considerably and added many new stochastic methods (MCPEM, SAEM and Bayesian). If you are interested to be able to optimize your population analysis by using these methods, POP-PHARM will support all your activities in that area. I strongly believe that the combination of workshops (especially through Iconus) and then unlimited support will allow you to best performing optimal Population Analysis. If you are interested to have more information about how does it work, please contact me at [email protected] and cc [email protected] (I still provide consulting to XOMA in both PK/PD modeling as well as decision analysis). Best Regards; Serge Guzy President, CEO, POP-PHARM; Inc. (tel) 510 559 91 97 (home) (cel) 510 542 76 48 (car phone) 510 418 78 23 -- The information contained in this email message may contain confidential or legally privileged information and is intended solely for the use of the named recipient(s). No confidentiality or privilege is waived or lost by any transmission error. If the reader of this message is not the intended recipient, please immediately delete the e-mail and all copies of it from your system, destroy any hard copies of it and notify the sender either by telephone or return e-mail. Any direct or indirect use, disclosure, distribution, printing, or copying of any part of this message is prohibited. Any views expressed in this message are those of the individual sender, except where the message states otherwise and the sender is authorized to state them to be the views of XOMA.
